![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | ||||
Founding Date | Founding Date 1935 | Founding Date 1978 | Founding Date 1944 | Founding Date 1984 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Mumbai, IN HQ Mumbai, IN Verna, IN | Locations Hyderabad, IN HQ Melbourne, AU São Paulo, BR Mississauga, CA Kunshan, CN Bogotá, CO Rueil Malmaison, FR see more |
Employees | Employees 27,764 | Employees 16,5612% increase | Employees 3,814 | Employees 27,0486% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ₹69.3b (FY, 2026) | Revenue (est.) ₹335.9b (FY, 2026) |
Cost of goods | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ₹36.9b (FY, 2026) | Cost of goods ₹122.4b (FY, 2026) |
Gross profit | Gross profit ₹195b (FY, 2026) | Gross profit ₹115.8b (FY, 2026) | Gross profit ₹35.2b (FY, 2026) | Gross profit ₹228.2b (FY, 2026) |
Net income | Net income ₹38.7b (FY, 2026) | Net income ₹3.7b (FY, 2026) | Net income ₹15.5b (FY, 2026) | Net income ₹41.6b (FY, 2026) |
Operating ⚠ | ||||
Dossiers Filed | Dossiers Filed 270 (FY, 2024) | Dossiers Filed N/A | Dossiers Filed N/A | Dossiers Filed 241 (FY, 2024) |
Drug Master Files Filed | Drug Master Files Filed 503 (FY, 2024) | Drug Master Files Filed N/A | Drug Master Files Filed N/A | Drug Master Files Filed 133 (FY, 2024) |

Biocon is a company that develops and manufactures biopharmaceutical products.
View companyAbbott India is a pharmaceutical company that offers medicinal drugs.
View company
Dr. Reddy's Laboratories is a company providing pharmaceutical services.
View company